COWEN AND COMPANY, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2021$1,711,000
+18.8%
972,176
+595.5%
0.16%
-34.0%
Q3 2020$1,440,000
-57.0%
139,781
-12.8%
0.24%
-57.7%
Q2 2020$3,345,000
+56.6%
160,216
-26.7%
0.56%
+13.5%
Q1 2020$2,136,000
-21.6%
218,624
-7.6%
0.49%
+106.8%
Q4 2019$2,725,000
+136150.0%
236,583
+688.6%
0.24%
+23600.0%
Q3 2019$2,00030,0000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$85,866,00042.72%
Versant Venture Management, LLC 7,003,892$146,241,265,00021.01%
ACUTA CAPITAL PARTNERS, LLC 1,746,500$36,467,00010.54%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$10,022,0005.33%
Ghost Tree Capital, LLC 900,000$18,792,0004.96%
RTW INVESTMENTS, LP 6,790,027$141,776,0003.99%
RA Capital Management 7,801,641$162,898,0003.17%
Avoro Capital Advisors LLC 7,585,000$158,375,0003.13%
FRAZIER MANAGEMENT LLC 1,437,028$30,005,0002.64%
Soleus Capital Management, L.P. 218,723$4,566,0002.60%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders